Retagliptin Phosphate
Tier C — Watch / tradeRetagliptin Phosphate
Targets：DPP4
Indications (approved)：Type 2 diabetes
Regional status
Factories producing this API3
Factories registered as producing this API in our sourcing network (RFQ records + product master), sorted by RFQ activity; the snapshot carries no cost or customer data.
3 producing factories on file — sign in to view the named list (factory details are not shown to guests).
Sign in to view factories →Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| RETAG-001 | 209995-38-0 | 2-(2,4,5-trifluorophenyl)acetic acid |
| RETAG-002 | 108-59-8Available | dimethyl malonate |
| RETAG-003 | 769195-26-8 | methyl 3-oxo-4-(2,4,5-trifluorophenyl)butanoate |
| RETAG-004 | 20989-17-7 | (S)-2-amino-2-phenylethanol |
| RETAG-005 | 1338939-58-4 | (S,E)-methyl 3-((2-hydroxy-1-phenylethyl)amino)-4-(2,4,5-trifluorophenyl)but-2-enoate |
| RETAG-006 | 1338939-59-5 | (S)-3-phenyl-5-(2,4,5-trifluorobenzyl)-3,4-dihydro-1,4-oxazepin-7(2H)-one |
| RETAG-007 | 1338939-60-8 | (3S,5R)-3-phenyl-5-(2,4,5-trifluorobenzyl)-1,4-oxazepan-7-one |
| RETAG-008 | 1358715-37-3 | methyl 3-(trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine-1-carboxylate |
| RETAG-009 | 1598419-96-5 | methyl 7-((R)-3-(((S)-2-hydroxy-1-phenylethyl)amino)-4-(2,4,5-trifluorophenyl)butanoyl)-3-(trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine-1-carboxylate |
| RETAG-010 | 1598419-97-6 | methyl 2-amino-2-(pyrazin-2-yl)acetate hydrochloride |
| RETAG-011 | 407-25-0 | 2,2,2-trifluoroacetic anhydride |
| RETAG-012 | 1598419-90-9 | methyl 2-(pyrazin-2-yl)-2-(2,2,2-trifluoroacetamido)acetate |
| RETAG-013 | 1598419-91-0 | methyl 3-(trifluoromethyl)imidazo[1,5-a]pyrazine-1-carboxylate |
Frequently asked questions
What are the approved indications of Retagliptin Phosphate?
Approved indications include: Type 2 diabetes.
When does the Retagliptin Phosphate patent expire?
No public expiry year is available for Retagliptin Phosphate yet; this page updates once verified.
How many synthesis routes are recorded for Retagliptin Phosphate?
1 synthesis routes are recorded; the shortest is 9 steps with 5.90 g total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Retagliptin Phosphate intermediates?
1 intermediate CAS of Retagliptin Phosphate are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.
How do I get a quote for Retagliptin Phosphate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29